Categories: HealthScience

Readmission to a different hospital is bad for heart patients, study finds

A new study finds that for patients who need to be readmitted to Canadian hospitals for heart failure, where they end up matters, as those readmitted to a different hospital tend to have longer hospital stays and higher mortality rates.

Heart failure occurs when the heart’s ability to pump blood has been compromised, for instance, as a result of coronary artery disease or high blood pressure. It can produce a range of symptoms from fatigue and shortness of breath to kidney and liver damage, arrhythmia and heart valve problems, and in Canada, the condition is on the rise.

About 600,000 Canadians currently live with heart failure, according to the Heart and Stroke Foundation, with 50,000 new cases diagnosed every year. In part, the rise stems from our being victims of our own success, as improvements in medical treatment for heart condition have led to higher survival rates for heart attacks and people being able to live longer with damaged hearts.

But heart failure also produces high rates of hospitalization and, importantly, readmission. Most patients get readmitted to the same hospital to which they were first admitted, as continuity of care and of information are known to be important considerations.

Readmission to a different hospital: “Every time a patient is admitted to a new hospital, it’s like starting from square one…”

“Every time a patient is admitted to a new hospital, it’s like starting from square one,” says Dr. Finlay McAlister of the University of Alberta and the Mazankowski Alberta Heart Institute in Edmonton and lead author of a new study on hospital readmissions, to Medscape.

But Dr. McAlister says that increasingly because of issues like hospital crowding and cost reductions, ambulances are taking patients to the nearby hospital with the shortest wait time, rather than ensuring that patients end up at hospitals where they had been previously seen or ones at which their physician admits patients.

Indeed, a 2010 study in the United States found that between 1993 and 2006, length of hospital stays decreased from 8.8 days to 6.3 days while 30-day readmission rates rose from 17.2 per cent to 20.1 per cent.

To get more perspective on the trend in Canada, Dr. McAlister and colleagues looked at medical records for 217,039 patients discharged from Canadian hospitals between April 2004 and December 2013 with a primary diagnosis of heart failure. Of that group, they found 39,368 (18.1 per cent) were readmitted within 30 days, with 83.2 per cent of that group being readmitted to their original hospital and 16.8 per cent (a little under one fifth) to a different one, representing a 2.9 per cent increase in other-hospital readmission between 2004 and 2013.

In terms of outcomes, those readmitted to a different hospital had an average hospital stay the second time around of 11.6 days versus only 10.4 for those who were readmitted to their original hospital. In-hospital mortality rates varied, too, with the different-hospital group having a 15.0 per cent mortality rate in comparison to 14.4 per cent for the same-hospital group.

The researchers see their results as speaking to the need to reconsider health care policy around ambulance services and putting less focus on shortening wait times in emergency rooms. “Given the poorer prognosis associated with alternate hospital readmission, our data suggest that clinicians should counsel patients on the potential benefits of returning to their original hospital if they deteriorate,” say the study’s authors.

The research is published in the Journal of the American Heart Association.

 

More from Cantech Science

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Chorus Aviation price target trimmed at CIBC

Following first quarter results, CIBC analyst Kevin Chiang has lowered his price target on Chorus Aviation (Chorus Aviation Stock Quote,… [Read More]

9 hours ago

Is Magellan Aerospace stock a buy?

Its first quarter results are in the books and Paradigm Capital analyst J Marvin Wolff thinks there is money to… [Read More]

1 day ago

Phunware is undervalued, Roth says

Ahead of the company's first quarter results, Roth MKM analyst Darren Aftahi thinks there is money to be made on… [Read More]

1 day ago

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

1 day ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

2 days ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

2 days ago